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Rickettsia parkeri, a recently identiﬁ   ed cause of 
spotted fever rickettsiosis in the United States, has been 
found in Amblyomma  triste ticks in several countries of 
South America, including Argentina, where it is believed 
to cause disease in humans. We describe the clinical and 
epidemiologic characteristics of 2 patients in Argentina with 
conﬁ  rmed  R. parkeri infection and 7 additional patients 
with suspected R. parkeri rickettsiosis identiﬁ   ed at 1 
hospital during 2004–2009. The frequency and character 
of clinical signs and symptoms among these 9 patients 
closely resembled those described for patients in the United 
States (presence of an inoculation eschar, maculopapular 
rash often associated with pustules or vesicles, infrequent 
gastrointestinal manifestations, and relatively benign 
clinical course). Many R. parkeri infections in South 
America are likely to be misdiagnosed as other infectious 
diseases, including Rocky Mountain spotted fever, dengue, 
or leptospirosis.
R
ickettsia parkeri, a tick-borne bacterium discovered 
in 1937, was considered nonpathogenic until 2004. 
Since 2004, >25 cases of R. parkeri rickettsiosis have been 
reported in persons living within the recognized range of 
the tick vector, Amblyomma maculatum, in the United 
States (1–4; Centers for Disease Control and Prevention, 
unpub. data). The clinical features of this newly recognized 
disease appear less severe than those produced by R. 
rickettsii bacteria, the agent of Rocky Mountain spotted 
fever (RMSF). For many years, investigators in several 
countries of South America, including Argentina, Brazil, 
and Uruguay, have recognized eschar-associated infections 
that clinically resemble R. parkeri rickettsiosis (5–7). These 
reports, and the discoveries of R. parkeri in A. triste ticks 
collected from these same countries, suggest that human 
infections with R. parkeri also occur in South America 
(8–10); to our knowledge, no conﬁ  rmed cases of disease 
caused by this Rickettsia species have been reported from 
this continent.
The Paraná Delta, situated in the provinces of Buenos 
Aires and Entre Ríos in Argentina, represents the terminus 
of the Paraná River as it approaches and drains into the 
Uruguay River and subsequently into the Río de la Plata. 
This alluvial ecosystem, where braided river branches 
create a network of islands and wetlands, covers ≈14,000 
km2 (5,405 mi2) and extends for ≈320 km (200 mi). This 
region also contains abundant populations of A. triste 
ticks (10). The Paraná Delta has always been a major 
agricultural and farming region. Recently, this area has 
become increasingly developed; roads have been built to 
allow greater access for tourism and recreational activities 
by many of the ≈14 million inhabitants of nearby Buenos 
Aires. In 2005, an eschar-associated febrile infection was 
diagnosed in a male beekeeper from the Paraná Delta; 
the infection was later conﬁ  rmed as a spotted fever group 
(SFG) rickettsiosis by serology and immunohistochemistry 
(5). He had been bitten by a tick not far from several sites 
where R. parkeri was subsequently detected in A. triste ticks 
(10). We report conﬁ  rmed cases of R. parkeri rickettsiosis 
in 2 patients in Argentina and describe additional suspected 
cases of this disease, or similar infections, in patients from 
the provinces of Buenos Aires, Chaco, and Entre Ríos.
Materials and Methods
Patients were identiﬁ  ed after referral to the Zoonosis 
Service of Hospital F.J. Muñiz in Buenos Aires Province, 
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Argentina. In each case, a rickettsial disease was 
considered from speciﬁ   c clinical signs and symptoms, 
including fever, rash, and an eschar, accompanying 
a history of recent tick bite. Serum and skin biopsy 
specimens were collected from these patients and 
evaluated by various assays to conﬁ  rm infection with an 
SFG Rickettsia species. Serum samples were tested for 
immunoglobulin (Ig) G reactive to antigens of R. parkeri 
and R. rickettsii by using indirect immunoﬂ  uorescence 
antibody assays, as described (1,3). Reciprocal antibody 
titers >64, or a 4-fold rise in titer, to either antigen were 
considered evidence of infection with an SFG Rickettsia 
species. When available, skin biopsy specimens were 
tested by using an immunoalkaline phosphatase technique 
to detect SFG rickettsiae in formalin-ﬁ  xed,  parafﬁ  n-
embedded tissues, as described (1,11), or by use of PCR.
For molecular evaluations, DNA was extracted from 
eschar biopsy specimens by using a QIAamp DNA Mini 
Kit (QIAGEN, Valencia, CA, USA). A segment of the 
rickettsial outer membrane protein B gene (ompB) was 
ampliﬁ   ed by using primers 120–2,788 and 120–3,599 
(12) in a 50-μL reaction mixture containing 5 μL of DNA 
template. A segment of the citrate synthase gene (gltA) 
was also ampliﬁ   ed by using primers CS78 and CS323 
(13) in a 40-μL reaction mixture containing 8 μL of DNA 
template. Ampliﬁ  ed gene segments, excluding primers, were 
compared with sequences in the GenBank database by using 
the Basic Local Alignment Search Tool (National Center for 
Biotechnology Information, www.ncbi.nlm.nih.gov). Gene 
sequences were aligned by using ClustalX software (14).
A suspected case was deﬁ   ned as a clinically and 
epidemiologically compatible illness, with >1 supportive 
serologic or immunohistochemical test results through use 
of group-speciﬁ  c assays for SFG Rickettsia spp. (11). A 
conﬁ  rmed case of R. parkeri rickettsiosis was deﬁ  ned by 
PCR ampliﬁ  cation of gene sequences speciﬁ  cally matching 
that of R. parkeri.
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Figure 1. Conﬁ  rmed and suspected cases of Rickettsia parkeri rickettsiosis, Argentina. The box (A) enlarged in panel (B) shows the extent 
of the area in which Argentinean provinces, representing patient exposure locations to ticks, are labeled and highlighted. A previous study 
(10) identiﬁ  ed ticks collected from the Paraná Delta near the city of Campana. Numbers of suspected and conﬁ  rmed cases of R. parkeri 
rickettsiosis, by province during 2004–2009, are shown in parentheses. The national capital city of Buenos Aires continues to experience 
rapid population growth into adjacent lands in and near the Paraná Delta. Rocky Mountain spotted fever, a more severe tick-borne 
rickettsiosis, has been described in the province of Jujuy in the northwestern corner of Argentina (15,16).R. parkeri Rickettsiosis, Argentina
Results
During 2004–2009, nine patients in Argentina with an 
SFG rickettsiosis were identiﬁ  ed at Hospital F.J. Muñiz. 
Three were women. Median age of patients was 53 years 
(range 38–76 years). All patients reported tick bites that 
occurred during August–January and preceded fever onset 
by a median of 6 days (range 4–15 days). Exposures to ticks 
were associated with recreational activities for 7 patients 
and outdoor labor for 2. Six patients sustained tick bites in 
the Paraná Delta; 2 other patients were bitten in rural areas 
of the province of Buenos Aires near the towns of Verónica 
and General Lavalle; and 1 was bitten in a rural area of the 
province of Chaco, known as “El Impenetrable” (Figure 1, 
panel B).
A painless inoculation eschar, ranging from 1 cm 
to 1.5 cm, developed in 8 patients at the site of the tick 
bite (Table; Figure 2). These lesions were located in the 
following regions: head (3 patients); back (2); and leg, hand, 
and abdomen (1 each). Multiple eschars were not identiﬁ  ed 
on any patient. Nonpruritic rashes developed in all patients 
and involved predominantly the trunk and extremities, 
represented by maculopapules on 8 patients, papulovesicles 
on 5 patients, and petechiae on 2 patients (Figure 2, panels 
B, C). Other commonly reported manifestations included 
headache and myalgias in 8 and 6 patients, respectively. 
Infrequently reported ﬁ   ndings included arthralgias (3 
patients); sore throat (2); and diarrhea, photophobia, and 
bilaterally injected conjunctivae (1 each). No patients 
required hospitalization, and all recovered rapidly after oral 
therapy with doxycycline.
Laboratory identiﬁ   cation of cases included serology 
for 7 patients, immunohistochemistry for 1, and PCR for 2. 
Seroconversion, deﬁ  ned as a 4-fold rise in titer, was identiﬁ  ed 
for 5 patients submitting paired serum samples, and 1 serum 
sample was positive in 2 patients; IgG titers to R. parkeri or 
R. rickettsii antigens ranged from 64 to 2,048. SFG Rickettsia 
spp. antigens were detected in formalin-ﬁ  xed,  parafﬁ  n-
embedded sections of eschar and papule biopsy specimens 
that showed histopathologic features (Figure 2, panel D) 
compatible with those described for R. parkeri rickettsiosis 
(3,11). Infection with R. parkeri was conﬁ  rmed speciﬁ  cally 
by molecular analyses of eschar biopsy specimens from 2 
patients whose histories are provided below. Amplicons of 
the expected sizes were obtained from both specimens by 
using the primers for the rickettsial ompB and gltA genes. 
Sequence analyses of ampliﬁ  ed  ompB segments showed 
100% identity with only the corresponding sequence of R. 
parkeri (GenBank accession no. AF123717). The next closest 
similarities were 711/714 (99%) with Rickettsia sp. BJ-90 
(accession no. AY331393), 711/714 (99%) with R. sibirica 
(accession no. AF123722), and 710/714 with R. africae 
(accession no. CP001612). Sequencing of 332 bp of the 
gltA gene showed 100% identity with R. parkeri (accession 
no. U59732) and with Rickettsia sp. strain S (accession no. 
U59735), R. sibirica (accession no. U59734), and Rickettsia 
sp. BJ-90 (accession no. AF178035). Complete identity was 
also seen with a smaller (309-bp) overlapping segment of the 
gltA gene of Rickettsia sp. Atlantic rainforest (accession no. 
GQ855235), Rickettsia sp. NOD (accession no. EU567177), 
and Rickettsia sp. COOPERI (accession no. AY362704).
Case Histories
Patient 1, a 48-year-old man, was referred to F.J. 
Muñiz Hospital in November 2008 with recurring fever 
(temperatures to 40ºC) associated with headache, neck 
pain, and rash. Six days before onset of these symptoms, 
he removed a tick attached to his abdomen, ≈24 hours after 
a ﬁ  shing expedition in the Paraná Delta in the province of 
Entre Ríos (Figure 1, panel B). A painless eschar developed 
at the bite site 6 days after the tick was removed. Physical 
examination indicated a febrile patient in otherwise good 
condition with a generalized, nonpruritic, maculopapular, 
and papulovesicular rash that involved predominantly his 
trunk and upper and lower limbs; his face, palms, or soles 
were not affected. His serum alanine aminotransferase level 
was 43 U/L (reference <31 U/L). All other hematologic and 
biochemistry measurements were within reference ranges. 
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Figure 2. Cutaneous lesions of patients with suspected and 
conﬁ  rmed Rickettsia parkeri rickettsiosis in Argentina. A) Eschar 
at the nape of the neck at the site of recent tick bite. B, C) 
Papulovesicular rash involving the back and lower extremities. 
D) Histopathologic appearance of a papule biopsy specimen, 
showing perivascular mononuclear inﬂ  ammatory cell inﬁ  ltrates and 
edema of the adjacent superﬁ  cial dermis and an intact epidermis 
(hematoxylin and eosin stain; original magniﬁ  cation ×100).SYNOPSIS
A serum sample and eschar and papule biopsy specimens 
were obtained, and the patient was treated empirically with 
doxycycline 200 mg/day for 6 days.
Patient 2, a previously healthy 55-year-old-man, 
was referred to F.J. Muñiz Hospital in January 2009 with 
fever (temperature 38.5°C), rash, headache, photophobia, 
conjunctival injection, myalgias, and arthralgias. Seven 
days before onset of symptoms, he had removed a tick from 
his back while camping in the Paraná Delta in the province 
of Buenos Aires (Figure 1, panel B), and a painless black 
eschar appeared subsequently at the bite site. Three days 
later, he visited a community clinic and received treatment 
(cephalexin, 500 mg every 6 hours) for presumed cellulitis, 
without improvement. The patient did not appear severely ill 
on physical examination. He had a generalized, nonpruritic 
maculopapular rash that involved predominantly his 
trunk and extremities but not his face, palms, or soles. 
Hepatomegaly or splenomegaly, and nuchal rigidity were 
not found. Laboratory tests showed a serum aspartate 
aminotransferase level of 67 U/L (reference range <31 
U/L), and alkaline phosphatase level of 270 U/L (reference 
range 40–129 U/L). All other hematologic and biochemical 
results were within reference ranges. A serum sample and 
an eschar biopsy specimen were obtained, and the patient 
was treated empirically with doxycycline (200 mg/d for 6 
days). His fever disappeared within 48 hours after starting 
treatment, and complete remission of symptoms occurred 
within 6 days.
Discussion
We conﬁ  rmed infection with R. parkeri in 2 patients 
bitten by ticks in the Paraná Delta region of Argentina and 
eschar-associated rickettsioses in 7 other patients from 
this region and other areas within Argentina (Figure 1, 
panel B). Because awareness of R. parkeri rickettsiosis by 
clinical practitioners in Argentina is low, and because it 
appears to be a self-limiting infection, it is likely that many, 
if not most, cases remain undiagnosed. All case-patients 
we studied had relatively mild illnesses similar to cases 
of R. parkeri rickettsiosis described in the United States. 
Indeed, the frequency and character of the clinical features 
of this disease among case-patients in Argentina closely 
resemble the signs and symptoms documented in patients 
in the United States (Table), including the occurrence of 
an eschar, a maculopapular rash often associated with 
pustules or vesicles, and the infrequency of gastrointestinal 
manifestations.
For several years, investigators suspected R. parkeri 
as a cause of at least some of the eschar-associated 
rickettsioses described in patients from several countries of 
South America (5,7–10). Our identiﬁ  cation of R. parkeri 
DNA in cutaneous lesions of 2 persons in Argentina 
provides deﬁ  nitive evidence for this Rickettsia species as 
a cause of disease on this continent. During a previous 
investigation, R. parkeri was detected in ≈8% of questing 
adult A. triste ticks collected in the lower Paraná Delta, 
near the city of Campana (Figure 1, panel B) (10). No ticks 
were saved by patients described in the present report for 
species identiﬁ  cation; however, most patients were bitten 
while at work or during leisure time in the Paraná Delta 
during August–November when adult A. triste ticks are 
relatively abundant and actively seeking hosts (10). Three 
cases originated far beyond the boundaries of the Paraná 
Delta, which suggests that infections with R. parkeri might 
occur in other regions of Argentina. It is also possible that 
other tick vectors may be involved in the transmission of 
R. parkeri or that other Rickettsia species are responsible 
for these distant cases. Tick- and ﬂ  ea-borne SFG Rickettsia 
spp. identiﬁ  ed recently in patients in Argentina and Brazil 
include R. felis, R. massiliae, and a Rickettsia sp. related 
closely to, but distinct from, R. parkeri (17–20).
Because the patients in this series typically had fever, 
rash, and myalgias, a diagnosis of leptospirosis or dengue 
was often considered during initial evaluation. These 
diseases are endemic across many provinces of northern 
Argentina, and some cases of R. parkeri rickettsiosis are 
likely to be misdiagnosed as dengue, leptospirosis, or other 
infectious diseases. Investigations in Mexico and Colombia 
have identiﬁ  ed SFG rickettsioses as common causes of 
fever among patients believed initially to be infected with 
dengue virus (15,16). RMSF, endemic in the province 
of Jujuy (Figure 1, panel B) and possibly other areas of 
Argentina, shares several clinical features with R. parkeri 
rickettsiosis. However, it is characteristically a more severe 
1172  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 7, July 2011
Table. Comparison of selected clinical characteristics reported for 
suspected and confirmed cases of Rickettsia parkeri rickettsiosis 
in patients from Argentina and the United States, 2004–2009* 
Clinical characteristic 
% Argentina 
patients, n = 10 
% United States 
patients, n = 15 
Fever 100 100
Inoculation eschar  90 93
Rash
 Any  type  100 87
  Macules or papules  90 87
  Vesicles or pustules  50 40
 Petechiae  20 13
  On palms or soles  20 43
Headache 90 80
Myalgias 70 80
Sore throat  30 NR† 
Injected conjunctivae  10 NR 
Lymphadenopathy 10 27
Diarrhea 10 0
Nausea or vomiting  0 7
Hospitalization 0 33
Death 0 0
*See (3,5,11).
†NR, not reported. R. parkeri Rickettsiosis, Argentina
infection that may result in death. By comparison, 6 of 10 
persons with conﬁ  rmed or probable RMSF in Jujuy during 
1993–2004 died from this infection, and the surviving 
patients were hospitalized (21,22). However, no deaths 
or hospitalizations were identiﬁ   ed among the patients 
with R. parkeri rickettsiosis reported here. Serologic and 
immunohistochemical tests cannot readily distinguish 
between these diseases because of cross-reactive epitopes; 
molecular methods are necessary to identify the speciﬁ  c 
etiologic agent.
The leading edge of the Paraná Delta is advancing 
steadily from the deposition of sediments and is expected 
to reach or surpass the boundaries of the city of Buenos 
Aires within the next 100 years (23). The long-term effects 
of this process on the distribution and frequency of R. 
parkeri rickettsiosis are difﬁ  cult to predict; however, as 
humans continue to encroach on the Paraná Delta through 
urbanization, agriculture, and tourism, recognized cases of 
this disease are likely to escalate.
Dr Romer is an infectious disease clinician and microbiologist 
at Hospital F.J. Muñiz in Buenos Aires, Argentina. Her current 
research interests include arthropod-borne diseases, particularly 
those caused by Rickettsia spp.
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